2022

1. The Impact of Vedolizumab and Ustekinumab on Articular Extra-Intestinal Manifestations in Inflammatory Bowel Disease Patients: A Real-Life Multicentre Cohort Study

   Journal of Crohn's & colitis, Vol. 16, Núm. 11, pp. 1676-1686